Skip to main content
Clinical Trials/CTRI/2022/02/039994
CTRI/2022/02/039994
Active, not recruiting
Phase 2

A clinical study to assess the efficacy of a treatment module including Shodhana followed by Shamana in the management of Benign Prostatic Hyperplasia (Mutraghata)

All India Institute of Ayurveda0 sites0 target enrollmentTBD

Overview

Phase
Phase 2
Intervention
Not specified
Conditions
Not specified
Sponsor
All India Institute of Ayurveda
Status
Active, not recruiting
Last Updated
2 years ago

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
2 years ago
Study Type
Interventional

Investigators

Eligibility Criteria

Inclusion Criteria

  • 1\. Patients diagnosed with BPH Grade I, II or III.
  • 2\. Patients having classical signs and symptoms of Mutraghata.
  • 3\. Patients fit for Anulomana and Uttara Basti.

Exclusion Criteria

  • 1\. Age below 40 years or above 80 years
  • 2\. Patients diagnosed with BPH Grade IV
  • 3\. Patients with malignancy, congenital deformities of urogenital tract or any pathology other than BPH
  • 4\. Patients with Diabetes Mellitus, Hypertension, Renal disorders or any other systemic disease
  • 5\. Patients unfit for Anulomana and Uttara Basti

Outcomes

Primary Outcomes

Not specified

Similar Trials